Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.
Coyle
Christina M
CM
Department of Medicine, Jacobi Medical Center, Bronx, NY 10461, USA. coyle@aecom.yu.edu
Weiss
Louis M
LM
Rhodes
Luther V
LV
Cali
Ann
A
Takvorian
Peter M
PM
Brown
Daniel F
DF
Visvesvara
Govinda S
GS
Xiao
Lihua
L
Naktin
Jaan
J
Young
Eric
E
Gareca
Marcelo
M
Colasante
Georgia
G
Wittner
Murray
M
D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D016817:Apansporoblastina / Q000302:isolation & purification*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D002544:Cerebral Infarction / Q000209:etiology; D009033:Culicidae / Q000469:parasitology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000069285:Infliximab; D008854:Microscopy, Electron; D016881:Microsporidiosis / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology / Q000635:transmission; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000469:parasitology* / Q000473:pathology / Q000648:ultrastructure; D009220:Myositis / Q000469:parasitology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D000981:Antiprotozoal Agents; D018501:Antirheumatic Agents; D000069285:Infliximab; D015766:Albendazole